Leo Pharma invested USD 70 million in biotech firm facing patent lawsuit
A US hospital claims the right to several patents that form the basis of biotech company Pellepharm's absolute main asset. Danish Leo Pharma signed a million-dollar deal with the firm in November last year.
A patent suit in California, US, is threatening US biotech firm Pellepharm, in which Danish company Leo Pharma recently invested millions.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
